JTJapan Times·1hHealth
score+0.60
BioNTech lung cancer drug extends survival versus chemotherapy
Original
BioNTech lung cancer drug extends survival versus chemotherapy
“Emphasizes significant survival extension and clinical success, framing a medical breakthrough with positive therapeutic outcomes.”